Pure Biologics is a biopharmaceutical company. We are conducting in-house research projects for the development of new biopharmaceutical drugs, diagnostics tests and therapeutical medical devices. Our company has a unique technological know-how with proprietary platforms for selection of antibody fragments and chemically modified aptamers. We are leveraging these technologies to employ biological binding entities for drug development and diagnostics. We are also providing fee-for- service contract research for pharmaceutical companies and academia, comprising recombinant proteins production in various cell systems and a broad protein analytics portfolio, as well as selection of custom antibody fragments and aptamers.